Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 18 Original Research Diabetes Prevention, Care and Management Authors Ghosal S , Ghosal A Received 22 October 2025 Accepted for publication 18 November 2025 Published 26 November 2025 Volume 2025:18 Pages 4347—4358 DOI https://doi.org/10.2147/DMSO.S575790 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Samit Ghosal
Efficacy and Safety of GLP‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
JCM | Free Full-Text | The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled Trials
2. Materials and Methods This review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [6]. Our review protocol was prospectively registered [7]. 2.1. Search Strategy and Eligibility Criteria The Cochrane Library electronic database was searched by the authors (S.G. and A.G.) without any date or language restrictions. The authors also manually searched for abstracts related to the topic.
P15 Comparative efficacy of pioglitazone and saroglitazar in non-alcoholic fatty liver disease: a Bayesian network meta-analysis
P15 Comparative efficacy of pioglitazone and saroglitazar in non-alcoholic fatty liver disease: a Bayesian network meta-analysis Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Read the full text or download the PDF: Read the full text or download the PDF:
Rise of Ayurveda: A Dangerous Trend to Decolonize the Scientific Method
Progress made in India in the past decade in digitization, banking reforms, and economic structuring has been phenomenal. However, there seems to be an inversely proportional relationship between economic/technological advancement and health/education in the present-day political India. It seems that the concept of going back to one’s roots has been exclusively reserved for health and education.
Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring - PubMed
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysis
Abstract Backgrounds and Aims Glucagon-like-peptides 1 receptor analogues (GLP1-RAs) have gained primacy in the management of type 2 diabetes (T2D). However, in contrast to the CVOT conducted with sodium glucose cotransporter-2 inhibitors (SGLT-2i) there was a significant reduction in glycated haemoglobin (HbA1c) in some of the CVOT with GLP1-RA. The aim of this analysis is to explore the possible association between cardiovascular outcome benefits with GLP1-RA and HbA1c reduction.
"Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey"
doi: 10.1016/j.dsx.2020.07.040. Online ahead of print. Kalyan Kumar Gangopadhyay 1 , Binayak Sinha 2 , Samit Ghosal 3 Affiliations Affiliations 1 Department of Diabetes & Endocrinology, Fortis Hospital, Peerless Hospital, 730, Eastern Metropolitan Bypass, Kolkata, India. Electronic address: jaykal69@hotmail.com. 2 Department of Diabetes & Endocrinology, Fortis Hospital, AMRI Hospital, 730, Eastern Metropolitan Bypass, 700107, Kolkata, India. Electronic address: binayak.sinha@gmail.com.
Meta-analyses of the effects of Dpp-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 GLP1-RA (Overall) Vs. Placebo on CV outcomes. Fig. 1 a: MI; Fig1 b: Stroke; Fig. 1 c: MI+stroke ; Fig1 d: CV Death; Fig. 1 e: hHF. ELIXA: Lixisenatide. LEADER: Liraglutide. SUSTAIN 6: Semaglutide. HARMONY: Albiglutide. EXSCEL: Exenatide LAR Fig. 2 GLP1-RA (LA) Vs. Placebo on CV outcomes. Fig. 2 a: MI; Fig2 b: Stroke; Fig. 2 c: MI+stroke ; Fig2 d: CV Death; Fig. 2 e: hHF.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Samit
Contact Samit, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack